Evolution of patient characteristics and outcomes in ATTR-CM clinical trials: A systematic review
{{output}}
Background: Over the past decade, advancements in awareness, diagnosis, and new treatment options for transthyretin amyloid cardiomyopathy (ATTR-CM) have likely influenced the characteristics of patient populations enrolled in cl... ...
